Deadline for First Proposals
This research programme seeks to advance high-value applications of redistributed manufacturing research that will transform future deployed medical care capability.
The current call for proposals is now OPEN.
The first deadline is 2pm on Friday 30th October 2020, with the expectation of a January 2021 project start date.
Research proposals will advance manufacturing engineering research in one of our four themes:
• Additive Manufacturing
• Cell & Tissue Manufacturing
• Clinical Fluids Manufacturing
• Pharmaceuticals Manufacturing
More details of our themes are available below.
Only UKRI qualifying institutions may apply for funding, the full list is available on the UKRI website.
Please request an ‘Application Form’ as early as possible using the link below.
We also invite organisations involved in advanced manufacturing R&D or providers of emergency and humanitarian care to collaborate with our projects using the ‘project collaboration’ link.
Key Information for Proposals
The RiHN has around £1.2m available for research projects, which will be awarded to successful proposals by its expert assessment panels. These panels will have cross-disciplinary representation and expertise from both academia and practice. We aim to award funding in tranches, with our first deadline for proposals being 2pm on Friday 30th October 2020. A second deadline is expected to be in early 2021, however, this is subject to availability of funding in each research theme and potential changes to our topics of interest. We reserve the right to close the funding competition earlier or extend deadlines.
Please give full consideration of the time needed to develop your research proposition, secure collaborators, and prepare the necessary institutional information and permissions. RiHN may be able to assist early career researchers to establish links with external partners, although this is not guaranteed and such requests should be made as early as possible. All awards are subject to EPSRC funding rules and institutional acceptance of conditions set out in the guidance.
This research is focused on the development and evaluation of field deployable Additive Manufacturing processes and systems for the creation of custom medical devices. Proposals may focus attention on where advances in Additive Manufacturing could deliver much needed availability of medical equipment, or the (re)design of bespoke products to better respond to emerging threats associated with medical emergencies. Please read the detailed guidance for more information and apply using the button below.
Cell & Tissue Manufacturing
This research is expected to lead the design and testing of cell and/or tissue interventions that deliver therapeutic effects for the treatment of traumatic injuries or result in improved rehabilitation post-trauma. This might include processes, strategies or devices covering allogeneic or autologous cell therapies, molecules to stimulate specific therapeutic responses from endogenous cell populations or cell and tissue transplantation. Pioneering studies are sought, with a focus on innovative utility under deployed medical care conditions. Please read the detailed guidance for more information and apply using the button below.
Clinical Fluid Manufacturing
This research seeks to address the operational pressures of deployed medical care in austere and extreme environments, where there is often limited access to essential life-saving clinical grade fluids and blood products. Focal areas may include development of innovative production technologies and processes, or adaptation of existing pioneering systems from other high technology sectors. There may be an emphasis on techniques to enhance survivability and transport of fluids and blood. Please read the detailed guidance for more information and apply using the button below.
This research seeks to advance the development of miniaturised portable device platform(s) and techniques capable of producing small-molecule active pharmaceutical ingredients (APIs) and therapeutic proteins (e.g. analgesics, anaesthesia, antibiotics) in deployed operations. This may extend to exploring the production of live biotherapeutics targeting the microbiome, the rapid development of vaccine and drugs, and innovative delivery of pharmaceuticals using 3D printers. Please read the detailed guidance for more information and apply using the button below.